| Home > Publications Database > Plasma Levels of Soluble AβPPβ as a Biomarker for Alzheimer's Disease with Dementia. |
| Journal Article | DZNE-2020-07008 |
; ; ; ; ; ; ; ; ; ; ; ; ; ;
2019
IOS Press
Amsterdam
This record in other databases:
Please use a persistent id in citations: doi:10.3233/JAD-181088
Abstract: Cost- and time-effective markers of Alzheimer’s disease (AD), reliable and feasible at the population level are urgently needed. Soluble amyloid-β protein precursor β (sAβPPβ) in plasma has attracted scientific attention as a potential AD biomarker candidate. Here we report that plasma sAβPPβ levels in patients with AD dementia and typical for AD cerebrospinal fluid (CSF) biomarker profiles (N = 33) are significantly lower (p < 0.01) than those of cognitively healthy elderly individuals without AD (N = 39), while CSF sAβPPβ levels did not differ between the studied groups. This provides further evidence for the potential of sAβPPβ in plasma as an AD biomarker candidate.
Keyword(s): Aged (MeSH) ; Alzheimer Disease: blood (MeSH) ; Alzheimer Disease: cerebrospinal fluid (MeSH) ; Alzheimer Disease: diagnosis (MeSH) ; Amyloid beta-Protein Precursor: blood (MeSH) ; Amyloid beta-Protein Precursor: cerebrospinal fluid (MeSH) ; Biomarkers: blood (MeSH) ; Biomarkers: cerebrospinal fluid (MeSH) ; Dementia: blood (MeSH) ; Dementia: diagnosis (MeSH) ; Female (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Middle Aged (MeSH) ; tau Proteins: cerebrospinal fluid (MeSH)
|
The record appears in these collections: |